Acta Scientific Microbiology (ISSN: 2581-3226)

Research Article Volume 6 Issue 4

Antimicrobial Effect of 1,25 Dihydroxy Vitamin D on Escherichia coli and its Association with Serum 25 Hydroxy Vitamin D Level: An Experimental Study on the Elderly Women

Joyeta Ghosh1*, Aditi Nag Chaudhuri2, Indranil Saha3 and Debnath Chaudhuri4

1Department of Dietetics and Applied Nutrition, Amity Institute of Applied Sciences (AIAS), Amity University - Kolkata Campus, Major Arterial Road, Action Area II, Kadampukur Village, Rajarhat, Newtown, Kolkata, West Bengal 700135, India.

2Department of Microbiology, Lady Brabourne College, University of Calcutta, Kolkata, India

3ICMR-Centre for Ageing & Mental Health, Indian Council of Medical Research, Salt Lake, Kolkata, West Bengal, India

4Department of Biochemistry and Nutrition, All India Institute of Hygiene & Public Health, Kolkata, West Bengal, India

*Corresponding Author: Joyeta Ghosh, Department of Dietetics and Applied Nutrition, Amity Institute of Applied Sciences (AIAS), Amity University - Kolkata Campus, Major Arterial Road, Action Area II, Kadampukur Village, Rajarhat, Newtown, Kolkata, West Bengal 700135, India.

Received: February 06, 2023; Published: March 13, 2023

Abstract

Introduction: Vitamin D plays crucial role as an antimicrobial agent, the deficiency of which has deleterious effects on the general wellbeing, especially among elderly. The incidence and severity of infectious diseases in the elderly are associated with a variety of functional, demographic and immunologic changes inside the body due to ageing.

Objective: The aim was to examine the association of vitamin D status with antimicrobial activity of cultured macrophages isolated within an exclusively elderly population cohort. In addition, the present study was also determined the antimicrobial activity (against E. coli infection) of cultured macrophages after in vitro supplementation of Vitamin D.

Materials and Methods: This experimental study was conducted among 97 randomly selected rural elderly women aged between 60 to 70 years of age, during the period of April 2014 to August 2018,at Amdanga block, North 24th parganas, West Bengal. Their vitamin D status was assessed by the estimation of serum 25(OH)D and classified into three groups viz. sufficient (40 members), insufficient (28 members) and deficient (29 members). After that the Peripheral Blood Mononuclear Cells (PBMC) were isolated and cultured from fresh blood from each and every study subject. Supplementation of 1,25 dihydroxy vitamin D[1,25(OH)2D] was given selectively at a dose of 10 ×10-8 M for 72 hours in the culture media and were exposed to Escherichia coli and screened for their iNOS activity (inducible Nitric Oxide Sythase), SOD activity (Superoxide Dismutase) and CFU (Colony Forming Unit) reduction rate. SPSS software, version 20.0 was used to perform statistical analysis.

Results: iNOS activity and SOD activity were significantly increased in case of both sufficient and deficient group. As per the CFU reduction rate against E. coli infection there is no significant difference were observed according to serum 25(OH)D consisting group. After in vitro 1,25(OH)2D supplementation,the maximum increase in CFU reduction rate was observed among Deficient group(63.57%), whereas in case of Insufficient group it was 60.11% and for Sufficient group it was 44.66%.

Conclusion: Considering bacteria killing capacity of macrophages the in vitro 1,25(OH)2D supplementation significantly inreases the CFU reduction rateoverall. Sufficient group’s macrophages always had better profile than other two groups. In vitro 1,25(OH)2D supplementation increases iNOS and SOD activity significantly.

 Keywords: E. coli; iNOS Activity; SOD Activity; Bacteria Killing Assay; Elderly Women

References

  1. CDC 2019. Centers for Disease Control and Prevention. Biggest Threats and Data Antibiotic/Antimicrobial Resistance| CDC (2019).
  2. Sadighi Akha AA. “Aging and the immune system: an overview”. Journal of Immunological Methods 463 (2018): 21-26.
  3. Tannaou T., et al. “Multifactorial immunodeficiency in frail elderly patients: Contributing factors and management”. Médecine et Maladies Infectieuses 49 (2019): 167-172.
  4. World Health Organization. “WHO global report on traditional and complementary medicine 2019”. World Health Organization (‎2019)‎. License: CC BY-NC-SA 3.0 IGO.
  5. Van B., et al. “Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data”. The Lancet Infectious Diseases8 (2010): 742-750.
  6. Chaudhry D and Tomar P. “Antimicrobial resistance: the next BIG pandemic”. International Journal of Community Medicine and Public Health 8 (2017): 2632-2636.
  7. Nelson RE., et al. “National Estimates of Healthcare Costs Associated with Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States”. Clinical Infectious Disease 72 (2021): S17-S26.
  8. Elias R., et al. “Aging, immune senescence, and immunotherapy: a comprehensive review”. Seminars Oncology 45 (2018): 187-200.
  9. Agarwal S and Busse PJ. “Innate and adaptive immunosenescence”. American college of Allergy Asthma Immunology 104 (2010): 183-190.
  10. Smet A., et al. “Comparative Analysis of Extended-Spectrum--Lactamase-Carrying Plasmids from Different Members of Enterobacteriaceae Isolated from Poultry, Pigs and Humans: Evidence for a Shared -lactam Resistance Gene Pool?”. Journal of Antimicrobial Chemotherapy 63 (2009): 1286-1288.
  11. Gothwal R and Shashidhar T. “Antibiotic Pollution in Environment :A review”. Clean Soil Air Water (2015): 479-489.
  12. Eleftheriadis T., et al. “The effect of paricalcitol on osteoprotegerin production by human peripheral blood mononuclear cells”. Journal of Rheumatology 36 (2009): 856-857.
  13. Hughes DA and Norton R. “Vitamin D and respiratory health”. In Clinical and Experimental Immunology 158.1 (2009): 20-25.
  14. Sertznig P., et al. “Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells”. Anticancer Research9 (2009): 3647-3658.
  15. Veldman CM., et al. “Expression of 1,25-dihydroxyvitamin D (3) receptor in the immune system”. Archives of Biochemistry and Biophysics 374 (2000): 334-338.
  16. Kamen DL and Tangpricha V. “Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity”. Journal of Molecular Medicine 88 (2010): 441-450.
  17. Ghosh J., et al. “Prevalence of metabolic syndrome, vitamin D level, and their association among elderly women in a rural community of West Bengal, India”. Medical Journal of Dr. D.Y. Patil University 13 (2020): 315-320.
  18. Vitamin D Fact Sheet for Health Professionals. US Department of Health and Human National Institute of Health Services”. Office of dietary supplements (2020).
  19. Tyurina YY., et al. “Nitrosative Stress Inhibits the Amino phospholipid Translocase Resulting in Phosphatidyl serine Externalization and Macrophage Engulfment Implications For The Resolution of Inflammation”. Journal of Biological Chemistry (2007): 665-668.
  20. Panaro MA., et al. “Evidence for iNOS expression and nitric oxide production in the human macrophages”. Current Drug Targets Immune Endocrine Metabolic Disorder3 (2003): 210-221.
  21. Dalton TP., et al. “Regulation of gene expression by reactive oxygen”. Annual Review of Pharmacology and Toxicology 39 (1999): 67-101.
  22. Segal AW and Abo A. “The biochemical basis of the NADPH oxidase of phagocytes”. Trends in Cell Biology 18 (1993): 43-47.
  23. BØyum A. “Isolation of mononuclear cells and granulocytes from human blood”. Scandinavian Journal of Clinical and Laboratory Investigation 21 (1968): 77-89.
  24. Nins RW., et al. “Colorimetric assays for NO species formed from NO stock solutions and donor compounds”. Methods in Enzymology (Ed.), 268 (1996): 93-205.
  25. Marklund SL and Marklund G. “Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase”. Journal of Biochemistry 47 (1974): 469 474.
  26. Lowry OH., et al. “Protein measurement with the Folin phenol reagent”. Journal of Biological Chemistry 193 (1951): 265-275.
  27. Angela H., et al. “Impairment of Antimicrobial Activity and Nitric Oxide Production in Alveolar Macrophages from Smokers of Marijuana and Cocaine”. The Journal of Infectious Diseases 187 (2003): 700-704.
  28. World Health Organization. “WHO Publishes List of Bacteria for Which New Antibiotics Are Urgently Needed” (2017).
  29. Woods J., et al. “Special feature for the Olympics: effects of exercise on the immune system: exercise-induced modulation of macrophage function”. Immunology Cell Biology 78 (2000): 545-553.
  30. Karimian P., et al. “Anti-oxidative and anti-inflammatory effects of Tagetesminuta essential oil in activated macrophages”. Asian Pacific Journal Tropical Biomedicine 4 (2014): 219-227.
  31. Fischbach M A and Walsh C T. “Antibiotics for Emerging Pathogens”. Science 325 (2009): 1089-1093.
  32. Chalmers JD., et al. “Vitamin D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis”. Thorax 68 (2013): 39-47.
  33. Zosky GR., et al. “Vitamin D deficiency causes deficits in lung function and alters lung structure”. American Journal Respiratory Critical Care Medicine 183 (2011): 1336-1343.
  34. Ainoosh G., et al. “Antimicrobial and immune-modulatory effects of vitamin D provide promising antibiotics-independent approaches to takle bacterial infections”. European Journal of Microbiology and Immunology3 (2019): 80-87.
  35. MacMicking J., et al. “Identification of NOS2 as a protective locus against tuberculosis”. Proceedings of National Academic of Sciences of the United States of America 94 (1997): 5243-5248.
  36. Mac Micking J., et al. “Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase”. Cell 81 (1995): 641-50.
  37. Aribi M., et al. “Bactericidal Activities against Staphylococcus aureus Are Enhanced In Vivo by Selenium Supplementation in a Dose-Dependent Manner”. PLoS ONE9 (1995): e0135515.
  38. Wang TT., et al. “1,25 dihydroxy vitamin D3 is a direct inducer of antimicrobial peptide gene expression”. Journal of Immunology29 (20048): 9-12.
  39. Martineau AR., et al. “IFN-gamma and TNf-independent vitamin D-inducible human suppression of mycobacteria: the role of Cathelicidin LL-37”. Journal Immunology 178 (2007): 7190-7198.
  40. Ghosh J., et al. “Cathelicidin LL-37 level in presence and absence of vitamin D in cultured macrophages isolated from elderly women”. Malaysian Journal of Nutrition 3 (2022): 327-334.
  41. Ghosh J., et al. “Antimicrobial Effect of 1,25 Dihydroxy Vitamin D on Vibrio cholerae and its Association with Serum 25-Hydroxy Vitamin D Level in Rural Elderly Women: An Experimental Study”. Journal of Clinical and Diagnostic Research10 (2021): 34-37.

Citation

Citation: Joyeta Ghosh., et al. “Antimicrobial Effect of 1,25 Dihydroxy Vitamin D on Escherichia coli and its Association with Serum 25 Hydroxy Vitamin D Level: An Experimental Study on the Elderly Women". Acta Scientific Microbiology 6.4 (2023): 27-34.

Copyright

Copyright: © 2022 Joyeta Ghosh., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days

Indexed In






News and Events


Contact US